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Abstract 
The medial and lateral efferent innervations originate from distinct parts of the superior olivary complex. Both use acetylcholine, 
respectively, to modulate the activity of outer hair cells (OHC), and spiral ganglion neurons (SGN) which are postsynaptic to the inner 
hair cells (IHC). Besides predominantly activating nicotinic receptors, acetylcholine recognizes muscarinic M3 receptors, whose the 
role(s) and cellular localization(s) are not yet firmly established. We used reverse transcription and polymerase chain reaction to amplify 
the M3 receptor cDNA in the rat and guinea pig organ of Corti and spiral ganglion. Then, we localized the M3 receptor mRNAs in 
cochleas and superior olivary complex of both species. The M3 receptor cDNA was amplified from samples of brain, organ of Corti and 
spiral ganglion. Indeed, its corresponding mRNA was localized in SGNs, OHCs and IHCs. However, in the apical turns, OHCs were 
often found unlabeled. In the superior olivary complex, M3 mRNAs were colocalized with choline acetyltransferase mRNAs in neurons 
of the lateral superior olive and ventral nucleus of the trapezoid body. These results suggest that the M3 receptor-induced inositol 
phosphate formation described in previous studies [21] takes place in both postsynaptic (SGNs, OHCs) and presynaptic components of 
efferent cochlear synapses, and in cells that are not contacted by efferents in the adult cochlea (IHCs). 
Keywords: Acetylcholine; Efferent innervation; Cochlea; Superior olivary complex; Guinea pig; Rat; Hybridization, in-situ; Reverse transcriptase-poly- 
merase chain reaction 
1. Introduction 
The neurosensory epithelium of the cochlea, the organ 
of Corti, is innervated by afferent and efferent nerve fibers 
(see [47] for a review). The sensory inner (IHC) and outer 
(OHC) hair cells are presynaptic to the dendrites of type I 
and type II primary auditory neurons (afferent neurons), 
respectively. These neurons are located in the spiral gan- 
glion and their axonal process projects to the cochlear 
nucleus. Two populations of brainstem neurons (efferent 
neurons) innervate the organ of Corti. They belong to 
either the lateral or the medial efferent systems according 
to their locations in the superior olivary complex and their 
sites of cochlear terminations. In rodents, lateral efferent 
neurons lie in the lateral superior olive (LSO), a nucleus 
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located laterally in the superior olivary complex, and pro- 
ject to the IHC region where they make axodendritic 
synapses with terminals of the type I afferent neurons in 
the so-called inner spiral bundle. Medial efferent neurons 
are located in medial subnuclei of the superior olivary 
complex, mainly the ventral nucleus of the trapezoid body 
(VNTB). Their axonic terminals directly synapse with the 
OHCs. 
A great amount of data indicates that acetylcholine is a 
major neurotransmitter for both efferent innervations and 
that it acts predominantly via nicotinic receptors (see [17] 
for a review). Conversely, little is known about the role 
played by muscarinic receptors in the cochlea. Available 
data indicate a link with the polyphosphoinositide sig- 
nalling pathway [2,21,31,32] which may occur via an 
activation of M3 receptors as it is suggested by pharmaco- 
logical studies on the inositol phosphate (IP) synthesis [21 ] 
and binding of [3H]quinuclidinyl benzilate [3]. This is in 
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agreement with polymerase chain reaction (PCR) data in 
the mouse cochlea [12] showing an expression of M3 
transcripts (which correspond to the pharmacologically 
defined M3 receptor [7,22]). In addition, ml and m5 genes 
coding IP-linked muscarinic receptors have also been re- 
ported [ 12]. 
The location of muscarinic receptors is still obscure. 
Conflicting data exist about an expression of muscarinic 
receptors by OHCs. It has been reported that isolated 
OHCs do not bind [3H]quinuclidinyl benzilate, suggesting 
that they lack muscarinic receptors [33], but that they have 
a Ca2+-dependent potassium conductance activated via 
muscarinic receptors presumably coupled to the IP 
metabolism [26]. M3 receptors may also be located else- 
where in the cochlea. Accordingly, the IP synthesis can be 
stimulated by the activation of muscarinic receptors in 
both the organ of Corti and the modiolus, a region which 
contains the spiral ganglion, formed by primary auditory 
neurons surrounded by a glial sheath, and the auditory 
nerve [4]. Indeed, the acetylcholine-stimulated IP synthesis 
may thus be related to the previously described 
[3H]quinuclidinyl benzilate binding sites in these cochlear 
regions [25,48]. 
In order to gain more insight into the anatomical local- 
ization of M3 receptors and into their putative role(s), we 
have used reverse transcriptase-polymerase chain reaction 
(RT-PCR) and in-situ hybridization (ISH) to detect mR- 
NAs encoding M3 receptors in the rat and guinea pig 
spiral ganglions and guinea pig organs of Corti. In order to 
verify a possible expression of presynaptic M3 receptors 
on efferent terminals, we have also used ISH to localize at 
the cellular level M3 receptor transcripts in the superior 
olivary complex from both species. In this case, we com- 
pared on serial sections the distribution of mRNAs encod- 
ing M3 receptors and choline acetyltransferase (CHAT). 
This enzyme was used as a marker for efferent neurons 
since all the LSO neurons and large VNTB neurons pro- 
jecting to the cochlea have previously been shown to be 
immunoreactive to ChAT [1,46]. This hypothesis that M3 
muscarinic receptors are expressed on efferent terminals 
was based on the report of a decrease in carbachol-induced 
IP formation after a section of the contralateral component 
of the medial efferent innervation at the floor of the IVth 
ventricle [4]. It was also based on the absence of a 
cholinergic projection to the superior olivary complex (see 
[23]). A preliminary account of these results has been 
given [39]. 
2. Material and methods 
2.1. Reverse transcriptase-polymerase chain reaction 
The pair of primers used was designed using the DNA- 
STAR program. The forward primer was 5'-GCTGCCTC- 
CCTGGAAAACTCTGC-Y, at position 1776-1798 of the 
rat M3 sequence (Genbank database accession no. M16407 
[6]). The reverse primer was 5'-GGGCGGCCTTCTTCT- 
CCTTGAT-3', at position 2220-2199. The predicted prod- 
uct length was 445 bp. 
The temporal bones of 15 rats and 15 guinea pigs were 
removed, and the cochleas dissected. They were further 
microdissected to isolate the spiral ganglion and the organ 
of Corti. The RNA was extracted with guanidinium thio- 
cyanate (GIBCO-BRL, Gaithersburg, MD) according to 
the manufacturer's instruction. The samples were treated 
with RNase-free DNase (Gen-Hunter Corp., MA) for 30 
rain at 37°C to remove residual contaminating DNA. One 
microgram of total RNA from the spiral ganglion and all 
the RNA prepared from the 30 organs of Corti (<  1 ~xg) 
were reverse-transcribed into cDNA, The reaction was 
catalysed by Superscript II reverse transcriptase lacking 
RNase H activity (GIBCO-BRL) using a random hexamer 
primer. The RNA and the hexamer random primer were 
combined in a thin-walled PCR tube (Perkin Elmer/Cetus, 
Norwalk, CT) and the volume was brought to 11.5 Ixl with 
DEPC-treated water. The sample was heated to 70°C for 
10 min in a model 9600 thermocycler (Perkin 
Elmer/Cetus) and then chilled on ice for 2 rain. The 
lbllowing solutions were then added: 2 OA of 200 mM 
Tris-HC1, pH 8.4, 1 txl of 500 mM KC1, 2 ~zl of MgC12, 1 
~1 of 0.1 M dithiothreitol, 0.5 ~1 of RNasin (Promega, 
Madison, WI) and 1 pA of 10 mM dNTP mix; the final 
volume was 19 pA. The samples were allowed to equili- 
brate at 37°C for 5 min. One microliter reverse transcrip- 
tase was then added and the samples incubated at 37°C for 
1 h. At the end of this incubation, the temperature was 
raised to 95°C for 5 min. After chilling the tubes on ice, 
the samples were briefly centrifuged and the cDNA ampli- 
fied by PCR using the M3 specific primers. The PCR was 
performed essentially as suggested by the manufacturers 
with minor modifications: 94°C for 45 s, 60°C for 1 min, 
and 72°C for 2 rain (38 cycles). The last cycle was 
followed by a 10 rain extension at 72°C. The PCR prod- 
ucts were analyzed by electrophoresis on 1.5% agarose 
gel. Rat or guinea pig brain cDNAs prepared in the same 
conditions were used as controls. 
2.2. In-situ hybridization 
Fifteen Wistar rats (240-250 g) and 10 guinea pigs 
(250-300 g) were used. The animals were deeply anes- 
thetized with sodium pentobarbital (rats: 60 mg/kg;  guinea 
pigs: 90 mg/kg)  and fixed intra-aortically with ice-cold 
1% paraformaldehyde in 0.1 M sodium phosphate buffer, 
pH 7.4. After the perfusion, the brainstems and the cochleas 
were rapidly removed, dissected and postfixed in the same 
fixative for 1 h at 4°C. The otic capsule and stria vascularis 
of the cochleas were carefully removed in the phosphate 
buffer. The tissues were then cryoprotected in the phos- 
phate buffer containing 20% sucrose and cut on a Re- 
ichert-Jung cryostat at a 10-12 ~m thickness for the 
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cochleas and at a 5 Ixm thickness for the serial sections 
through the superior olivary complex. The sections were 
either used immediately for ISH or stored at -70°C until 
use .  
The oligonucleotides probes used in these experiments 
were purified by high performance liquid chromatography 
and their purity was confirmed using polyacrylamide gel 
electrophoresis. The M3 receptor antisense probe was 48 
bases long. It was complementary to the sequence (4-51) 
of the coding region of the rat M3 receptor gene [20]. It 
was purchased from New England Nuclear (Boston, MA). 
The two ChAT oligonucleotide antisense probes were 30 
and 36 bases long. They were complementary to bases 
128-170 and 281-316 of the rat sequence [8], respec- 
tively. They were synthesized by Clontech (Palo Alto, 
CA). 
The probes were labeled by a 3'-end-tailing procedure 
using terminal transferase. The labeling was initiated by 
incubating 1 nmol digoxigenin (DIG, Boehringer-Man- 
nheim, Germany) or 2.5 nmol biotin-16-dUTP (Enzo 
Biochem Co., New York) for 30 min at 37°C with 10 pmol 
(biotin labeling) or 100 pmol (DIG labeling) oligonucleo- 
tide, 4 Ixl of 5 × terminal transferase labeling buffer (1 M 
potassium cacodylate, 0.125 M Tris-HC1, 1.25 mg/ml  
bovine serum albumin, pH 6.6), 40 nmol dATP and 50 U 
of terminal transferase (Boehringer-Mannheim, Germany). 
The final volume was adjusted to 20 Ixl with double-dis- 
tilled water. The reaction was stopped by adding 1 p,1 of 
0.5 M EDTA, pH 7.2, then 0.5 p,g of tRNA (Sigma, St. 
Louis, MO). The probes were then precipitated with 
ethanol/4 M sodium chloride (2.5:0.1; v /v )  and kept at 
-20°C until use. Just before use, the probes were cen- 
trifuged at 12000 × g for 1 h. The supernatant was re- 
moved, the pellet containing the probe was dried under 
vacuum and then resuspended in the hybridization buffer 
(50% formamide, 4 X sodium chloride/sodium citrate 
(SSC; SSC 1 × =0.15 M sodium chloride, 0.015 M 
sodium citrate, pH 7), 1 ×Denhardt's solution (0.02% 
Ficoll, 0.02% polyvinylpyrolidone and 0.02% bovine serum 
albumin), 0.5% L-laurylsarcosine, 10% dextran sulfate, 0.5 
mg/ml  sheared single-stranded salmon sperm DNA). 
The sections were soaked at room temperature in the 
pre-hybridization buffer (4 × SSC; SSC, 1 × Denhart's so- 
lution, 0.5% L-laurylsarcosine) then dehydrated through 
70%, 80%, 95% and absolute ethanol (3 min each). After 
air drying, the sections were incubated overnight at 42°C 
with 10 Ixl of hybridization buffer containing 0.2 pmol of 
biotinylated or DIG-labeled probe. After the hybridization, 
the sections were dipped in 4 × SSC, rinsed in 1 × SSC (1 
h at room temperature and then 1 h at 40°C) then in 
0.1 × SSC (1 h at 40°C). They were then processed for 
biotin or DIG-detection, according to the probe used. 
Biotinylated hybrids were detected by the streptavidin-al- 
kaline phosphatase method. Tissue sections were rinsed in 
buffer A (1 M NaC1, 0.1 M Tris, 0.05 M MgC12, 0.5% 
Tween 20, pH 7.5; 3 x 20 min at room temperature) and 
incubated for 30 rain at room temperature with strepta- 
vidin-alkaline phosphatase diluted 1 : 100 (Dako, Glostrup, 
Denmark). DIG-labeled hybrids were processed using an 
alkaline phosphatase-labeled anti-DIG antibody (Boeh- 
ringer-Mannheim). The sections were then rinsed in buffer 
A (3 × 10 min), in buffer B (1 M NaC1, 0.1 M Tris, 0.05 
M MgC12, pH 9.5; 2 × 10 min), and in buffer C (0.5 M 
NaCI, 0.1 M Tris, 0.05 M MgC12, pH 9.5; 5 min). The 
alkaline phosphatase activity was revealed overnight in the 
dark with 0.33 mg/ml  nitroblue tetrazolium and 0.16 
mg/ml  5-bromo-4-chloro-3-indolyl phosphate as chro- 
mogens (Bethesda Research Laboratories, Gaithersburg, 
MD). The reaction was stopped by rinsing the sections for 
10 min in buffer A, then for 10 min in double-distilled 
water. To clearly distinguish labeled neurons from the 
background, we did not counterstain sections before 
mounting. The sections were observed on a Reichert Poly- 
var microscope using Normarski optics. 
To detect M3 mRNAs in the organ of Corti, which are 
badly preserved in cryostat sections, we hybridized in toto 
guinea pig cochleas. These cochleas were dissected as 
described above for cryosectioning, preincubated with 0.2 
M HC1 (1 h, 60°C; [19]) and incubated with the hybridiza- 
tion buffer (1 h) without the probe. They were then 
immersed in 30 Ixl of hybridization buffer containing 0.6 
pmol of the DIG-labeled M3 probe and hybridized 
overnight at 42°C. The subsequent steps of the procedures 
were identical to those described just above for the cryo- 
stat sections. After the development of the alkaline phos- 
phatase activity, the cochleas were cut on the cryostat and 
the 10-1×m-thick sections were mounted and observed 
using Nomarski optics. 
3. Results 
3.1. Reverse transcriptase-polymerase chain reaction 
Fig. 1 shows agarose gel electrophoresis of PCR prod- 
ucts from rat cDNA. The cDNA corresponding to M3 
1 2 3 4  5 
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Fig. 1. Agarose gel electrophoresis of PCR products amplified from rat 
brain, organ of Corti and spiral ganglion with specific primers for M3 
receptor sequence. Lane 1: 1-kb ladder standard; lane 2: brain; lane 3: 
spiral ganglion; lane 4: organ of Corti; lane 5: negative control without 
reverse transcriptase. The bands are labeled in units of kb pairs (1-kb 
DNA ladder standard; GIBCO-BRL). 
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receptors were amplified from the brain samples of  rats 
and guinea pigs (not shown). The band of  interest had the 
molecular size of  the expected PCR product, thus indicat- 
ing the effectiveness of  our PCR primers to drive the 
synthesis of  the M3 sequence. The M3 band was likewise 
retrieved in the samples of  spiral ganglion and organ of  
Corti from the two species. As negative controls, one of  
the primers or reverse transcriptase was omitted. In both 
cases, no cDNA was amplified. This rules out the possibil- 
ity of  a false-positive amplification from genomic DNA. 
3.2. In-situ hybridization 
Since no difference was observed between rat and 
guinea pig, we describe our results irrespective of  the 
. . . . .  
\ 
species, although most of  the figures illustrate guinea pig 
data only. 
3.2.1. Control tissues 
No hybridization signal could be observed in the sec- 
tions or cochleas except for an unspecific staining of  the 
spiral limbus and, occasionally, the tectorial membrane of  
the organ of  Corti. These control experiments were per- 
formed on alternate brainstem and spiral ganglion sections, 
and on cochleas hybridized in toto. They consisted in 
hybridizing the tissues with labeled sense probes (CHAT: 
synthesized by Clontech; M3: New England Nuclear, 
shown in Fig. 2A,D and 3A), with labeled antisense probes 
in the presence of  an excess of unlabeled antisense probes, 
without labeled antisense probes or with an irrelevant 
\ 
Fig. 2. Sections through the spiral ganglion of the guinea pig cochlea (A-C) and the organ of Corti (D,E). The sections have been hybridized with 
DIG-labeled M3 sense (A,D) and antisense (B,C,E) oligoprobes. No hybridization signal can be seen on the primary auditory neurons (A) or the inner 
(IHC) and outer (OHCs) hair cells in D. B (basal turn) and C (apical turn): nearly all the neurons express the M3 mRNAs. However, at both cochlear 
levels, some neurons, located peripherally in the ganglion, do not express the transcript (arrows). The thin arrows in B, C and the insert in B point on glial 
cells ensheathing the primary auditory neurons which do not express the transcript. E (from the second turn of the cochlea): both the OHCs and the IHC 
display an intense M3 signal. Scale bars: 50 ~m (A-C); 100 ~m (D,E). 
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30-base long oligonucleotide probe complementary to the 
calcitonin-specific region of the calcitonin/CGRP cDNA 
(New England Nuclear). 
3.2.2. Cochleas 
In both rat and guinea pig cochleas, the hybridization 
signal was uniformly distributed all along the entire spiral 
ganglion. The M3 receptor mRNAs were localized in 
nearly all large type I neurons, which were darkly stained 
(Fig. 2B,C). The preservation of the sections did not 
enable us to distinguish clearly the minor population of 
small type II neurons from that of large type I neurons. 
: % . ~1 
2 '  "~ • 
L , , 
This prevented an evaluation of the extent of the M3 
mRNA expression in type II neurons. However, small 
neurons mainly located at the periphery of the ganglion, 
similarly to type II neurons, did not express M3 mRNAs 
(Fig. 2B,C). We also observed that satellite glial cells 
surrounding the large type I neurons were not labeled (Fig. 
2B,C), thus probably ruling out a glial participation in the 
cDNA amplification described above. This also precludes 
a participation of M3 receptors of glial origin in the 
muscarinic binding [25,48] and the carbachol-evoked IP 
synthesis in the central region of the cochlea [4]. 
In the guinea pig organ of Corti from cochleas hy- 
Fig. 3. Sections through the guinea pig (A-C)  and rat (D,E) lateral superior olive. A: the Section has been hybridized with a biotinylated M3 sense probe. 
Only background signal can be seen on this section. B,C and D,E: low and high magnifications, respectively, of serial sections hybridized with choline 
acetyltransferase (CHAT, B,D) or M3 (C,E) antisense biotinylated oligoprobes. The arrowheads in B,C and arrows in D,E point on neurons which express 
both ChAT and M3 mRNAs. Star: blood vessels. Scale bars: 250 txm (A-C);  100 ixm (D,E). 
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bridized in toto, the M3 receptors hybrids were detected in 
the OHCs. All the OHCs from the lower cochlear turns 
were intensely labeled (Fig. 2E). Unlabeled OHCs could 
be seen in the upper turns and at the most apical level, no 
labeled OHCs could be found (not shown). An intense M3 
mRNA expression was also detected in the IHCs all along 
the length of the organ of Corti (Fig. 2E). 
3.2.3. Superior olivary complex 
3.2.3.1. Lateral superior olive. In both the rat and guinea 
pig LSO, the M3 hybridization signal was observed in 
small spindle-shaped neurons (mean diameter: 15 ~m) 
preferentially located in the medial limb. A similar obser- 
vation was made in the serial sections hybridized with the 
antisense ChAT probes, in agreement with previous data 
dealing with ChAT mRNAs [38] and protein [37,46]. In- 
deed, when comparing the serial sections, we observed a 
one-to-one colocalization of the M3 and ChAT mRNAs in 
these small spindle-shaped neurons (Fig. 3). 
3.2.3.2. Ventral nucleus of the trapezoid body. In the 
VNTB of both species, we also observed a one-to-one 
colocalization of the M3 and ChAT mRNAs in two popu- 
lations of neurons (Fig. 4). One of these populations of 
neurons (Fig. 4) was formed by large multipolar neurons 
(mean diameter: 25 Ixm). These neurons were mainly 
located in the dorso-lateral part of the nucleus (Fig. 4A,B). 
The second population of colocalized neurons was mainly 
located in the ventro-medial part of the VNTB and was 
Fig. 4. Serial sections through the guinea pig (A,B) and rat (C,D) ventral nucleus of the trapezoid body (VNTB). The sections shown have been hybridized 
with DIG-labeled ChAT antisense (A,C) or M3 antisense (B,D) probes. A,B: two populations of VNTB neurons expressing both ChAT and M3 mRNAs 
can be identified (thick arrows: large dorso-lateral neurons; thin arrows: small ventro-medial neurons). The top of A,B is oriented upward and the left side 
medialward. C,D: higher magnification of colocalized large-sized neurons. Scale bars: 100 ~ m  (A,B), 50 Ixm (C,D). 
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formed by small neurons (mean diameter: 15 txm; Fig. 
4A,B). These small neurons probably corresponded to the 
small ChAT-like immunoreactive VNTB neurons which 
project to the cochlear nucleus [41]. 
4. Discussion 
Our present data describing the amplification of M3 
cDNAs from rat and guinea pig spiral ganglions and 
organs of Corti, and the localization of M3 mRNAs at the 
cellular level in these cochlear regions confirm at a gene 
level the pharmacological and electrophysiological data 
involving muscarinic receptors in cochlear physiology [17]. 
Our results are also consistent with the pharmacological 
data involving the M3 muscarinic receptor subtypes in the 
carbachol-induced IP formation in rat cochleas. 
Previous experiments have associated the carbachol-in- 
duced IP formation with OHCs and medial efferent 
synapses [2,31], particularly since a peak of carbachol- 
stimulated IP formation occurred at the time at which 
medial efferent fibers established synaptic contact with 
OHCs [2]. More recent experiments have suggested that 
the carbachol-stimulated IP formation also occurred in 
other places of the cochlea [4]. The expression of the M3 
receptor cDNA in the spiral ganglion, the localization of 
its corresponding mRNA in primary auditory neurons, 
OHCs and IHCs, and in ChAT mRNA-containing neurons 
of the LSO and VNTB therefore suggest that the previ- 
ously described muscarinic receptor-stimulated IP forma- 
tion in the cochlea [2,21,31,32] takes place in several loci 
(postsynaptic, presynaptic or 'non-synaptic'). 
4.1. Postsynaptic expression of M3 receptors in hair cells 
The M3 mRNAs presence in the OHCs agrees with the 
whole body of data (reviewed in [17]) associating acetyl- 
choline with the medial efferent synapses with the OHCs. 
Particularly, it fits with the ability of acetylcholine to 
induce atropine-sensitive calcium mobilization [11] and 
outward currents [11,15,26] in isolated OHCs. These out- 
ward currents were furthermore suppressed by 4-diphenyl- 
acetoxy-N-methyl piperidine methiodide (4-DAMP), a M3 
antagonist [15,26]. Due to the calcium mobilizing ability of 
the IP-linked M3 receptors, one can thus speculate that this 
muscarinic cholinoceptor type is involved in the calcium- 
dependent motile behavior of isolated OHCs [13,40]. This 
motile behavior observed in vitro may be involved in the 
suppressive effects of the olivocochlear efferent activation 
on distortion product otoacoustic emissions in vivo. Ac- 
cordingly, it has been reported that muscarinic receptors 
may be involved in these suppressive effects [28], albeit 
they are primarily mediated by nicotinic receptors [28,42]. 
The detection of M3 mRNAs in the IHCs was unex- 
pected since it was widely agreed that, in the adult cochlea, 
IHCs lack efferent synapses (see [36]). However, whatever 
the species studied was, immature IHCs have been re- 
ported to be transiently contacted synapticaly by efferent 
fibers during the maturation of the cochlea, some days 
before the monitoring of the first cochlear responses 
[29,35,43]. In addition, transient efferent synapses have 
also been described on adult IHCs the days following an 
excitotoxic destruction of the radial afferent dendrites [34]. 
It has not yet been reported whether adult or immature 
IHCs that are transiently contacted by efferent terminals 
express functional M3 receptors. If this could be demon- 
strated, this would suggest that adult IHCs retain their 
potential to express M3 mRNAs, and maybe M3 receptors, 
in response to certain physiological conditions. This fits 
with preliminary results according to which acetylcholine 
blocks the ATP-induced Ca 2÷ mobilization in IHCs which 
have been isolated and maintained in culture conditions 
[50]. Such a line of reasoning could also apply for the 
newly described c~9-subunit of nicotinic receptor which is 
also expressed by rat IHCs [14]. 
4.2. M3 receptors in type I neurons 
The M3 cDNA expression by spiral ganglion samples 
and particularly the M3 mRNA expression by type I 
neurons fit with a postsynaptic expression of M3 receptors 
on peripheral processes in the inner spiral bundle, just 
beneath the IHCs. These peripheral (dendritic) processes 
are contacted en passant by ChAT-like immunoreactive 
lateral efferents [16]. Acetylcholine has been shown to 
have a facilitatory effect on the subsynaptic afferent spon- 
taneous or glutamate-evoked spiking activity [18]. This 
cholinergic facilitation occurred within several seconds, a 
latency which is consistent with the activation of 
metabotropic receptors such as the M3 receptor. However, 
no pharmacology has been done yet to ascribe this cholin- 
ergic effect to a given cholinergic receptor subtype. 
Our ISH results also suggest that M3 receptors would 
be expressed presynapticaly by the axonal processes of 
type I neurons in the cochlear nucleus. This would fit with 
the description of muscarinic binding sites [25,48] and 
carbachol-stimulated IP synthesis [4] in the central region 
of the cochlea, including the cochlear nerve. This would 
also fit with the fact that the axonal processes of type I 
neurons project on the same targets as axonic collaterals of 
cholinergic efferent neurons [5,9,49] and/or  axons of the 
recently described small moderately ChAT-like immuno- 
reactive VNTB neurons [41 ]. 
4.3. Presynaptic expression of M3 receptors at lateral and 
medial cholinergic medial efferent synapses? 
We have also localized M3 receptor mRNAs in ChAT 
mRNAs-expressing neurons of the LSO and VNTB. Previ- 
ous data based on retrograde tracing techniques combined 
with neurotransmitter labeling techniques have shown that 
the cochlea is innervated by LSO neurons and large VNTB 
neurons which strongly express a ChAT-like immuno- 
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staining [1,46]. ChAT- l ike  immunos ta ined  neurons of  the 
L S O  belong to the lateral efferent  innervat ion while the 
large neurons o f  the V N T B  belong to the medial  efferent  
innervation.  The  small ChAT- l ike  immunoreac t ive  neurons 
in the V N T B  form an additional neuronal  populat ion which 
innervates the cochlear  nucleus [41]. It can thus be consid-  
ered f rom our present observat ions  o f  M 3 / C h A T  m R N A  
colocal iza t ion that L S O  neurons and large V N T B  neurons 
belong to the lateral and media l  efferent  innervat ions to the 
cochlea,  respect ively,  and that the small  V N T B  neurons 
belong to the cochlear  nucleus innervation.  Whe the r  these 
M3 receptors correspond to possible postsynaptic  receptors 
on the efferent  neurons is still an open quest ion since no 
chol inergic  innervat ion o f  the L S O  and the V N T B  has 
been descr ibed yet. Indeed, the avai lable data concerning 
neurotransmit ters  used by innervat ions  ending in the LSO 
or the V N T B  rather deal with amino  acids, ei ther in- 
hibitory or  exci tatory (see [23]). It is thus conce ivable  that 
M3 receptors are expressed presynapt icaly by the axonic 
terminals  of  these neurons. Concern ing  the medial  efferent 
innervation,  such a presynaptic expression of  M3 receptors 
would  agree with the recent report  of  a partial but signifi- 
cant decrease of  the carbachol-s t imulated IP Iormat ion in 
the rat cochlea  after a section at the f loor of  the IVth 
ventr icle  of  the contralateral  componen t  o f  the medial  
efferent  innervat ion [4]. 
Avai lab le  data in other  nervous tissues or organs sug- 
gest  an invo lvemen t  o f  M3 autoreceptors  in a down-regu-  
lation o f  the acetylchol ine  release [10,44,51]. In addit ion to 
such an inhibit ion of  acetylchol ine  release, a regulat ion of  
the release of  coexis t ing transmitters a n d / o r  of  transmit- 
ters of  surrounding lateral and medial  efferent synapses 
may  also be speculated. Lateral  efferents may use at least 
f ive other  neurotransmitters  than acetylchol ine  ( G A B A ,  
dopamine,  enkephalins,  dynorphins  and C G R P )  and medial  
efferents  at least two others ( G A B A ,  CGRP) ,  which all 
could coexist  within the same neurons (see [17]). It has 
been reported that the release of  dopamine  in the striatum 
[27,30] and met-enkephal in  in the superior  col l iculus  [24] 
are s t imulated by muscar inic  receptors,  while  that of  G A B A  
in the d iencephalon is b locked [45]. It is thus tempting to 
speculate s imilar  modula tory  funct ions in cochlear  efferent  
terminals.  
In conclusion,  according to our data, muscarinic  recep- 
tors o f  the M3 subtype can be expressed on the presynaptic 
and postsynaptic  sides o f  efferent  synapses of  the organ of  
Corti,  and presumably  non-synapt icaly  in the IHCs. This 
suggests that the ace ty lchol ine- induced IP turnover  and its 
subsequent  ca lc ium mobi l iza t ion  play key roles in the 
metabol i sm of  hair cells, pr imary auditory neurons and 
efferent  terminals.  
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